Target intelligence / Profile preview

Class I and II Histone Deacetylases (Class I/II HDACs)

Target
Class I/II HDACs
Molecular classification
Enzyme, Histone modification, Zinc-dependent hydrolase, Transcription factor regulator
01

Overview

Class I and II Histone Deacetylases (HDACs) represent a critical family of zinc-dependent enzymes that modulate the epigenetic landscape by removing acetyl groups from lysine residues on histones and various non-histone proteins (UniProt, 2023). Class I HDACs (1, 2, 3, and 8) are ubiquitously expressed and primarily nuclear, playing a central role in cell proliferation and survival, whereas Class II HDACs (4, 5, 6, 7, 9, and 10) show tissue-specific expression and shuttle between the nucleus and cytoplasm to regulate diverse cellular processes (StatPearls, 2023). By maintaining histones in a deacetylated state, these enzymes facilitate a condensed chromatin conformation that typically represses gene transcription (NIH, 2024). In oncology, the dysregulation or overexpression of HDACs is a well-documented mechanism for the silencing of tumor suppressor genes, making them high-priority therapeutic targets (PubMed: Li et al., 2020). Small molecule HDAC inhibitors (HDACis) function by chelating the zinc ion in the active site, leading to hyperacetylation and the subsequent reactivation of genes that trigger cell cycle arrest and apoptosis in malignant cells (PubChem, 2024). While several HDACis are currently FDA-approved for hematological malignancies like T-cell lymphoma and multiple myeloma, the field is evolving toward more selective inhibitors to mitigate the systemic toxicities associated with pan-HDAC inhibition (FDA, 2023).

Other names
Histone deacetylasesKDACsLysine deacetylasesZinc-dependent HDACsHDAC family
02

Mechanism of action

The primary mechanism of action involves the competitive inhibition of the zinc-dependent catalytic domain of Class I and II HDACs, which prevents the removal of acetyl groups from lysine residues (PubMed: Seto & Yoshida, 2014). This inhibition results in the hyperacetylation of histone tails, promoting an open chromatin structure (euchromatin) that facilitates the transcription of genes involved in growth regulation and apoptosis, such as p21 (NIH, 2024). Beyond histones, these enzymes also regulate the acetylation of non-histone substrates including p53, alpha-tubulin, and Hsp90, thereby influencing protein stability, intracellular transport, and DNA repair pathways (StatPearls, 2023).

03

Biological functions

Epigenetic regulationGene expression regulationCell cycle regulationApoptosisProtein deacetylationChromatin remodelingDNA repair
04

Disease associations

CancerCutaneous T-cell lymphomaPeripheral T-cell lymphomaMultiple myelomaNeurodegenerative diseaseInflammationCardiovascular disease
05

Safety considerations

ThrombocytopeniaNeutropeniaGastrointestinal toxicity (nausea, diarrhea)FatigueQT interval prolongationTeratogenicity
06

Interacting drugs

Vorinostat

9 more in the full profile.

07

Biomarkers

Acetylated Histone H3Acetylated Histone H4p21 (WAF1/CIP1) expressionHR23B protein levels

Beyond the preview

Go deeper on Class I and II Histone Deacetylases (Class I/II HDACs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Class I and II Histone Deacetylases (Class I/II HDACs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call